DUBAI, United Arab Emirates, Nov. 29, 2025 (GLOBE NEWSWIRE) — Mutuum Finance (MUTM) is moving rapidly through its offering stages as the project reports that Phase 6 has now reached 99% allocation. With only a small portion of tokens remaining at the current price, community interest continues to build as the protocol prepares for its […]

Mutuum Finance (MUTM) Approaches 99% Stage Allocation of Phase 6 Ahead of Q4 V1 Launch GlobeNewswire November 29, 2025 DUBAI, United Arab Emirates, Nov. 29, 2025 (GLOBE NEWSWIRE) — Mutuum Finance (MUTM) is moving rapidly through its offering stages as the project reports that Phase 6 has now reached 99% allocation. With only a small

(NASDAQ:SNPS), NEW YORK, Nov. 29, 2025 (GLOBE NEWSWIRE) — Leading securities law firm Bleichmar Fonti & Auld LLP announces that a class action lawsuit has been filed against Synopsys, Inc. (NASDAQ: SNPS) and certain of the Company's senior executives for securities fraud after a significant stock drop resulting from the potential violations of the federal

SNPS STOCK: Lose Money on Your Synopsys, Inc. Investment? Contact BFA Law about the Pending Securities Class Action before December 30 Deadline GlobeNewswire November 29, 2025 NEW YORK, Nov. 29, 2025 (GLOBE NEWSWIRE) — Leading securities law firm Bleichmar Fonti & Auld LLP announces that a class action lawsuit has been filed against Synopsys, Inc.

(NASDAQ:MLTX), NEW YORK, Nov. 29, 2025 (GLOBE NEWSWIRE) — Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against MoonLake Immunotherapeutics (NASDAQ: MLTX) and certain of the Company's senior executives for potential violations of the federal securities laws. If you invested in MoonLake, you are encouraged to obtain

MLTX STOCK: Lose Money on Your MoonLake Immunotherapeutics Investment? Contact BFA Law about the Pending Securities Class Action before December 15 Deadline GlobeNewswire November 29, 2025 NEW YORK, Nov. 29, 2025 (GLOBE NEWSWIRE) — Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against MoonLake Immunotherapeutics (NASDAQ: MLTX)

(NYSE:LRN), NEW YORK, Nov. 29, 2025 (GLOBE NEWSWIRE) — Leading securities law firm Bleichmar Fonti & Auld LLP announces that a class action lawsuit has been filed against Stride, Inc. (NYSE: LRN) and certain of the Company's senior executives for securities fraud after significant stock drops resulting from the potential violations of the federal securities

LRN STOCK: Lose Money on Your Stride, Inc. Investment? Contact BFA Law about the Pending Securities Class Action before January 12 Deadline GlobeNewswire November 29, 2025 NEW YORK, Nov. 29, 2025 (GLOBE NEWSWIRE) — Leading securities law firm Bleichmar Fonti & Auld LLP announces that a class action lawsuit has been filed against Stride, Inc.

(NYSE:JHX), NEW YORK, Nov. 29, 2025 (GLOBE NEWSWIRE) — Leading securities law firm Bleichmar Fonti & Auld LLP announces that a class action lawsuit has been filed against James Hardie Industries plc (NYSE: JHX) and certain of the Company's senior executives for securities fraud after a significant stock drop resulting from the potential violations of

JHX STOCK: Lose Money on Your James Hardie Industries plc Investment? Contact BFA Law about the Pending Securities Class Action before December 23 Deadline GlobeNewswire November 29, 2025 NEW YORK, Nov. 29, 2025 (GLOBE NEWSWIRE) — Leading securities law firm Bleichmar Fonti & Auld LLP announces that a class action lawsuit has been filed against